Position in ZTS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$8,910
-$26,198 QoQ
Shares Held
124
-58.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,250
of 1,408 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WPG Advisers, LLC holds $113,342 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
90 | $48,764 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
102 | $17,191 | |
| 3 | VTRS |
Viatris Inc
|
564 | $8,956 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
124 | $8,910 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
321 | $7,899 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
291 | $7,382 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
148 | $6,883 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
80 | $3,781 |
All Filings in ZTS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,910 | 124 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $35,108 | 297 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $37,871 | 301 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $59,405 | 406 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $66,278 | 425 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $71,293 | 433 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $70,711 | 434 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||